PAX1/SOX1 DNA methylation and cervical neoplasia detection

A Taiwanese Gynecologic Oncology Group (TGOG) study

Hung Cheng Lai, Yu Che Ou, Tze Chien Chen, Huei Jean Huang, Ya-Min Cheng, Chi Hau Chen, Tang Yuan Chu, Shih Tien Hsu, Cheng Bin Liu, Yao Ching Hung, Kuo Chang Wen, Mu Hsien Yu, Kung Liahng Wang

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We aimed to determine whether PAX1/SOX1 methylation could be translated to clinical practice for cervical neoplasia detection when used alone and in combination with current cytology-based Pap screening. We conducted a multicenter case-control study in 11 medical centers in Taiwan from December 2009 to November 2010. Six hundred seventy-six patients were included in the analysis, including 330 in the training set and 346 in the testing set. Multiplex quantitative methylation-specific polymerase chain reaction (PCR) was performed with a TaqMan probe system using a LightCycler 480 Real-Time PCR System (Roche). The level of human papilloma virus (HPV) was analyzed using a Hybrid Capture 2 system (Digene). Receiver operating characteristic curves were generated to obtain the best cutoff values from the training data set. The sensitivities, specificities, and accuracies were validated in the testing set. The sensitivities for methylated (m) PAX1m and SOX1m and HPV testing for detecting CIN3+ lesions were 0.64, 0.71, and 0.89, and the specificities were 0.91, 0.77, and 0.68, respectively. Combined parallel testing of PAX1m/SOX1m tests with Pap smearing showed superior specificity (0.84/0.71 vs. 0.66, respectively) and similar sensitivity (0.93/0.96 vs. 0.97) to the combination of Pap smear results and HPV testing. Thus, combined parallel testing using Pap smears and PAX1 or SOX1 methylation tests may provide better performance than a combination of Pap smears with HPV testing in detection for cervical neoplasia.

Original languageEnglish
Pages (from-to)1062-1074
Number of pages13
JournalCancer Medicine
Volume3
Issue number4
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Papillomaviridae
Papanicolaou Test
Methylation
Neoplasms
Taiwan
ROC Curve
Cell Biology
Case-Control Studies
Real-Time Polymerase Chain Reaction
Sensitivity and Specificity
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Lai, Hung Cheng ; Ou, Yu Che ; Chen, Tze Chien ; Huang, Huei Jean ; Cheng, Ya-Min ; Chen, Chi Hau ; Chu, Tang Yuan ; Hsu, Shih Tien ; Liu, Cheng Bin ; Hung, Yao Ching ; Wen, Kuo Chang ; Yu, Mu Hsien ; Wang, Kung Liahng. / PAX1/SOX1 DNA methylation and cervical neoplasia detection : A Taiwanese Gynecologic Oncology Group (TGOG) study. In: Cancer Medicine. 2014 ; Vol. 3, No. 4. pp. 1062-1074.
@article{23302a40a87d42629d7c8f75f15f9888,
title = "PAX1/SOX1 DNA methylation and cervical neoplasia detection: A Taiwanese Gynecologic Oncology Group (TGOG) study",
abstract = "We aimed to determine whether PAX1/SOX1 methylation could be translated to clinical practice for cervical neoplasia detection when used alone and in combination with current cytology-based Pap screening. We conducted a multicenter case-control study in 11 medical centers in Taiwan from December 2009 to November 2010. Six hundred seventy-six patients were included in the analysis, including 330 in the training set and 346 in the testing set. Multiplex quantitative methylation-specific polymerase chain reaction (PCR) was performed with a TaqMan probe system using a LightCycler 480 Real-Time PCR System (Roche). The level of human papilloma virus (HPV) was analyzed using a Hybrid Capture 2 system (Digene). Receiver operating characteristic curves were generated to obtain the best cutoff values from the training data set. The sensitivities, specificities, and accuracies were validated in the testing set. The sensitivities for methylated (m) PAX1m and SOX1m and HPV testing for detecting CIN3+ lesions were 0.64, 0.71, and 0.89, and the specificities were 0.91, 0.77, and 0.68, respectively. Combined parallel testing of PAX1m/SOX1m tests with Pap smearing showed superior specificity (0.84/0.71 vs. 0.66, respectively) and similar sensitivity (0.93/0.96 vs. 0.97) to the combination of Pap smear results and HPV testing. Thus, combined parallel testing using Pap smears and PAX1 or SOX1 methylation tests may provide better performance than a combination of Pap smears with HPV testing in detection for cervical neoplasia.",
author = "Lai, {Hung Cheng} and Ou, {Yu Che} and Chen, {Tze Chien} and Huang, {Huei Jean} and Ya-Min Cheng and Chen, {Chi Hau} and Chu, {Tang Yuan} and Hsu, {Shih Tien} and Liu, {Cheng Bin} and Hung, {Yao Ching} and Wen, {Kuo Chang} and Yu, {Mu Hsien} and Wang, {Kung Liahng}",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/cam4.253",
language = "English",
volume = "3",
pages = "1062--1074",
journal = "Cancer Medicine",
issn = "2045-7634",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

Lai, HC, Ou, YC, Chen, TC, Huang, HJ, Cheng, Y-M, Chen, CH, Chu, TY, Hsu, ST, Liu, CB, Hung, YC, Wen, KC, Yu, MH & Wang, KL 2014, 'PAX1/SOX1 DNA methylation and cervical neoplasia detection: A Taiwanese Gynecologic Oncology Group (TGOG) study', Cancer Medicine, vol. 3, no. 4, pp. 1062-1074. https://doi.org/10.1002/cam4.253

PAX1/SOX1 DNA methylation and cervical neoplasia detection : A Taiwanese Gynecologic Oncology Group (TGOG) study. / Lai, Hung Cheng; Ou, Yu Che; Chen, Tze Chien; Huang, Huei Jean; Cheng, Ya-Min; Chen, Chi Hau; Chu, Tang Yuan; Hsu, Shih Tien; Liu, Cheng Bin; Hung, Yao Ching; Wen, Kuo Chang; Yu, Mu Hsien; Wang, Kung Liahng.

In: Cancer Medicine, Vol. 3, No. 4, 01.01.2014, p. 1062-1074.

Research output: Contribution to journalArticle

TY - JOUR

T1 - PAX1/SOX1 DNA methylation and cervical neoplasia detection

T2 - A Taiwanese Gynecologic Oncology Group (TGOG) study

AU - Lai, Hung Cheng

AU - Ou, Yu Che

AU - Chen, Tze Chien

AU - Huang, Huei Jean

AU - Cheng, Ya-Min

AU - Chen, Chi Hau

AU - Chu, Tang Yuan

AU - Hsu, Shih Tien

AU - Liu, Cheng Bin

AU - Hung, Yao Ching

AU - Wen, Kuo Chang

AU - Yu, Mu Hsien

AU - Wang, Kung Liahng

PY - 2014/1/1

Y1 - 2014/1/1

N2 - We aimed to determine whether PAX1/SOX1 methylation could be translated to clinical practice for cervical neoplasia detection when used alone and in combination with current cytology-based Pap screening. We conducted a multicenter case-control study in 11 medical centers in Taiwan from December 2009 to November 2010. Six hundred seventy-six patients were included in the analysis, including 330 in the training set and 346 in the testing set. Multiplex quantitative methylation-specific polymerase chain reaction (PCR) was performed with a TaqMan probe system using a LightCycler 480 Real-Time PCR System (Roche). The level of human papilloma virus (HPV) was analyzed using a Hybrid Capture 2 system (Digene). Receiver operating characteristic curves were generated to obtain the best cutoff values from the training data set. The sensitivities, specificities, and accuracies were validated in the testing set. The sensitivities for methylated (m) PAX1m and SOX1m and HPV testing for detecting CIN3+ lesions were 0.64, 0.71, and 0.89, and the specificities were 0.91, 0.77, and 0.68, respectively. Combined parallel testing of PAX1m/SOX1m tests with Pap smearing showed superior specificity (0.84/0.71 vs. 0.66, respectively) and similar sensitivity (0.93/0.96 vs. 0.97) to the combination of Pap smear results and HPV testing. Thus, combined parallel testing using Pap smears and PAX1 or SOX1 methylation tests may provide better performance than a combination of Pap smears with HPV testing in detection for cervical neoplasia.

AB - We aimed to determine whether PAX1/SOX1 methylation could be translated to clinical practice for cervical neoplasia detection when used alone and in combination with current cytology-based Pap screening. We conducted a multicenter case-control study in 11 medical centers in Taiwan from December 2009 to November 2010. Six hundred seventy-six patients were included in the analysis, including 330 in the training set and 346 in the testing set. Multiplex quantitative methylation-specific polymerase chain reaction (PCR) was performed with a TaqMan probe system using a LightCycler 480 Real-Time PCR System (Roche). The level of human papilloma virus (HPV) was analyzed using a Hybrid Capture 2 system (Digene). Receiver operating characteristic curves were generated to obtain the best cutoff values from the training data set. The sensitivities, specificities, and accuracies were validated in the testing set. The sensitivities for methylated (m) PAX1m and SOX1m and HPV testing for detecting CIN3+ lesions were 0.64, 0.71, and 0.89, and the specificities were 0.91, 0.77, and 0.68, respectively. Combined parallel testing of PAX1m/SOX1m tests with Pap smearing showed superior specificity (0.84/0.71 vs. 0.66, respectively) and similar sensitivity (0.93/0.96 vs. 0.97) to the combination of Pap smear results and HPV testing. Thus, combined parallel testing using Pap smears and PAX1 or SOX1 methylation tests may provide better performance than a combination of Pap smears with HPV testing in detection for cervical neoplasia.

UR - http://www.scopus.com/inward/record.url?scp=84904107608&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904107608&partnerID=8YFLogxK

U2 - 10.1002/cam4.253

DO - 10.1002/cam4.253

M3 - Article

VL - 3

SP - 1062

EP - 1074

JO - Cancer Medicine

JF - Cancer Medicine

SN - 2045-7634

IS - 4

ER -